BioNTech (NASDAQ:BNTX – Get Free Report) had its target price dropped by analysts at HC Wainwright from $150.00 to $145.00 in ...

In the latest quarter, 6 analysts provided ratings for BioNTech (NASDAQ:BNTX), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

BioNTech SE (NASDAQ:BNTX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eighteen brokerages that are covering the company, MarketBeat.com reports. Three research ...

View Our Latest Stock Report on BioNTech BioNTech Stock Down 0.2 % NASDAQ BNTX opened at $86.65 on Wednesday. BioNTech SE has a 1-year low of $76.53 and a 1-year high of $131.49. The company has a ...

BioNTech SE (NASDAQ:BNTX – Free Report) – Research analysts at HC Wainwright increased their Q1 2025 earnings estimates for shares of BioNTech in a note issued to investors on Tuesday ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of BioNTech SE (Symbol: BNTX) entered into oversold territory, hitting an RSI reading of 29.3 ...

Vaccine stocks have been under significant pressure in recent days following news that the FDA director who oversaw the ...

Mitsubishi UFJ Asset Management Co. Ltd. reduced its stake in BioNTech SE (NASDAQ:BNTX – Free Report) by 20.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The ...